Anzeige
❌
Mehr »
Dienstag, 17.11.2026 - Börsentäglich über 12.000 News
GBC-Kursziel 2,00 CAD bis Juni 2027, Kurs 0,67 CAD: Verdreifachung drin?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
NA

WKN: A2P5V2 | ISIN: SE0005454873 | Ticker: 4YD
Frankfurt
16.11.26 | 08:09
0,005 Euro
0,00 % 0,000
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NANOLOGICA AB Chart 1 Jahr
5-Tage-Chart
NANOLOGICA AB 5-Tage-Chart

Aktuelle News zur NANOLOGICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.11.Nanologica AB: Mark Quick assumes CEO Position at Nanologica AB405On October 23, 2026, Nanologica AB (publ) announced that Mark Quick has been appointed as the new CEO, provided that the Swedish Companies Registration Office grants an exemption from the requirement...
► Artikel lesen
02.11.Listing Of Units Rights And Paid Subscription Units Of Nanologica AB376With effect from November 03, 2026, the units rights of Nanologica AB will be traded on the list for Equity rights. Trading will continue up until and including November 12, 2026. ...
► Artikel lesen
28.10.XFRA CAPITAL ADJUSTMENT INFORMATION - 28.10.2026690Das Instrument 27V0 NL0015002IE0 AVANTIUM N.V. EO - 1 EQUITY wird ex Kapitalmassnahme gehandelt am 28.10.2026 The instrument 27V0 NL0015002IE0 AVANTIUM N.V. EO - 1 EQUITY is traded ex capital adjustment...
► Artikel lesen
23.10.Nanologica AB: Nanologica Resolves On A Partially Guaranteed Rights Issue Of Units Of Appx. Sek 110.5 Million With An Oversubscription Option Of An Additional Sek 10 Million454The Board of Directors of Nanologica AB (publ) ("Nanologica" or the "Company") has today, based on the authorization granted by the Annual General Meeting on 21 May 2026, resolved on a new issue of...
► Artikel lesen
NANOLOGICA Aktie jetzt für 0€ handeln
23.10.Nanologica AB: Nanologica Updates Strategy And Appoints New Ceo To Drive Commercial Growth And Profitability361Nanologica AB has updated its strategy focusing on accelerating commercial growth, broadening the offering, and increasing focus on North America and Europe. To lead the next phase of development, the...
► Artikel lesen
31.08.Nanologica AB Q2 Sales Increase1
31.08.Nanologica AB: Interim Report Q2 2026 Nanologica AB (publ)711FINANCIAL SUMMARYNet sales for the second quarter amounted to SEK 24,297 thousand (2,327) and for the half-year to SEK 45,753 thousand (13,079).Operating profit for the quarter amounted to SEK -18,073...
► Artikel lesen
21.05.Nanologica AB: Bulletin from the Annual General Meeting 2026 Nanologica AB (publ)529Nanologica AB (publ) today May 21, 2026 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted. Adoption of the income statement and balance sheet, disposition...
► Artikel lesen
20.05.Nanologica AB: Interim Report Q1 2026 Nanologica AB (publ)700FINANCIAL SUMMARYNet sales for the first quarter amounted to SEK 21,456 thousand (10,751).Operating profit for the quarter amounted to SEK 66,484 thousand (-9,241). Operating profit is affected by the...
► Artikel lesen
27.04.Nanologica AB: Syntagon AB Recruits Alexandra Pichard Nielsen as Vice President Business Development961Syntagon AB, a subsidiary of Nanologica AB (publ), has recruited Alexandra Pichard Nielsen to the newly established role of Vice President Business Development. The recruitment is part of the strategy...
► Artikel lesen
26.03.Nanologica AB: Nanologica Announces Outcome of Rights Issue1.000NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
06.03.Nanologica AB: Nanologica Publishes Information Document Regarding Directed Share Issues and Rights Issue873NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
05.03.XFRA CAPITAL ADJUSTMENT INFORMATION - 05.03.2026571Das Instrument 4YD SE0005454873 NANOLOGICA AB EQUITY wird cum Kapitalmassnahme gehandelt am 05.03.2026 und ex Kapitalmassnahme am 06.03.2026 The instrument 4YD SE0005454873 NANOLOGICA AB EQUITY is traded...
► Artikel lesen
04.03.Nanologica AB: Bulletin From The Extraordinary General Meeting In Nanologica AB (publ)538Nanologica AB (publ) ("Nanologica" or the "Company") held an extraordinary general meeting today at which the following resolutions were passed. For more detailed information on the content of the resolutions...
► Artikel lesen
26.02.Nanologica AB: Year-End Report 2025 Nanologica AB (publ)675FINANCIAL SUMMARYNet sales for the fourth quarter amounted to SEK 5,205 thousand (6,715) and for the full year to SEK 21,127 thousand (14,538)Operating loss for the quarter amounted to SEK -15,706 thousand...
► Artikel lesen
02.02.Flerie AB: Flerie's portfolio company Nanologica acquires Syntagon748Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon'), a contract manufacturer with 45 employees. The acquisition strengthens Nanologica's production capacity...
► Artikel lesen
30.01.Nanologica AB: Nanologica Carries Out Directed Share Issues Of Approx. Sek 13.7 Million In Total, And A Fully Secured Rights Issue Of Approx. Sek 82.5 Million952NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
29.01.Ardena Holding NV.: Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica912Ghent, Belgium, 29th January 2026 - Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1